Atossa Therapeutics (GB:0HJ7)

Atossa Therapeutics (0HJ7) Financial Statements


Atossa Therapeutics Financial Overview

Atossa Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Atossa Therapeutics is scheduled to report earnings on August 16, 2023, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -7.13M$ -8.37M$ -8.21M$ -6.59M$ -4.75M
EBITDA$ -7.13M$ -8.37M$ -8.20M$ -6.59M$ -4.75M
Net Income Common Stockholders$ 7.92M$ -7.49M$ -8.01M$ -6.67M$ -4.79M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 103.98M$ 111.00M$ 117.37M$ 125.54M$ 131.49M
Total Assets$ 115.46M$ 123.53M$ 126.72M$ 134.05M$ 137.48M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -103.98M$ -111.00M$ -117.37M$ -125.54M$ -131.49M
Total Liabilities$ 2.94M$ 5.57M$ 2.87M$ 3.79M$ 2.32M
Stockholders Equity$ 113.26M$ 117.96M$ 123.86M$ 130.26M$ 135.16M
Cash Flow-
Free Cash Flow$ 111.11M-$ -5.42M$ -5.95M$ -4.89M
Operating Cash Flow$ 111.11M-$ -5.41M$ -5.95M$ -4.88M
Investing Cash Flow--$ -2.71M$ 0.00$ -13.00K
Financing Cash Flow--$ 0.00$ 0.00$ 0.00
Currency in USD

Atossa Therapeutics Earnings and Revenue History

Atossa Therapeutics Debt to Assets

Atossa Therapeutics Cash Flow

Atossa Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis